share_log

開拓藥業-B:自願公告 - KX-826治療脫髮長期安全性III期試驗完成首例患者入組

KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST PATIENT ENROLLMENT IN LONG-TERM SAFETY PHASE III TRIAL OF KX-826 FOR TREATMENT OF AGA

香港交易所 ·  Jul 19, 2023 07:59
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more